SeaCrest Wealth Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,170
Closed -$58K 1346
2022
Q2
$58K Buy
+4,170
New +$55.8K 0.01% 1053
2019
Q2
Sell
-235
Closed -$5K 1610
2019
Q1
$5K Buy
235
+6
+3% +$114 ﹤0.01% 1730
2018
Q4
$4K Buy
229
+5
+2% +$101 ﹤0.01% 1773
2018
Q3
$5K Buy
224
+219
+4,380% +$4.96K ﹤0.01% 1875
2018
Q2
$0 Hold
5
﹤0.01% 2278
2018
Q1
$0 Hold
5
﹤0.01% 2273
2017
Q4
$0 Buy
+5
New +$99 ﹤0.01% 2244

Other funds holding SBRA

SeaCrest Wealth Management's SBRA Position: Q3 2022 in Review

SeaCrest Wealth Management sold out of Sabra Healthcare REIT (SBRA) in Q3 2022, closing a stake of 4,170 shares — an estimated $58K sold.

SeaCrest Wealth Management first reported a position in SBRA in Q4 2017 and held it in 7 quarters. The position peaked at $58K in Q2 2022. 332 funds tracked by Wall St. Rank hold SBRA as of Q3 2022.

  • SeaCrest Wealth Management reported no remaining Sabra Healthcare REIT position as of Q3 2022 after selling out during the quarter.
  • SeaCrest Wealth Management sold 4,170 Sabra Healthcare REIT shares in Q3 2022, an estimated $58K.
  • SeaCrest Wealth Management first reported a position in Sabra Healthcare REIT in Q4 2017 and held it in 7 quarters.
  • SeaCrest Wealth Management's Sabra Healthcare REIT position peaked at $58K in Q2 2022.
  • 332 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2022.

Based on SeaCrest Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.